Bharat Biotech awaits booster dose nod for intranasal vaccine iNCOVACC

Bharat Biotech’s intranasal vaccine iNCOVACC has got the Indian regulator’s approval, but there is still…

Covaxin booster dose may give long-term immunity: Bharat Biotech

Booster shot of Bharat Biotech’s whole-virus inactivated Covid-19 vaccine Covaxin (BBV152) may give…

Govt to procure 66 crore more doses of Covishield, Covaxin at revised rates

Image Source : PTI Govt to procure 66 crore more doses of Covishield, Covaxin at revised…

Decision on Emergency Use Listing of Covaxin likely in August first week: WHO

Image Source : AP Decision on emergency use listing of Covaxin likely in 4-6 weeks: WHO…

As Moderna readies to make an entry into India, list of other COVID-19 vaccine options available

New Delhi: Indian drugmaker Cipla Ltd has received regulatory approval to distribute partner Moderna Inc’s COVID-19 vaccine…

Covaxin Overall 77.8% Effective, Claims Bharat Biotech In Phase 3 Data

Covaxin has received emergency use authorizations in 16 countries, Bharat Biotech said. New Delhi: Bharat Biotech’s…

Covaxin 77.8% effective against symptomatic Covid-19, says Bharat Biotech

Bharat Biotech on Saturday announced safety and efficacy analysis data from phase III…

Covaxin has overall vaccine efficacy of 77.8%, claims Bharat Biotech in results from Phase 3 trials

New Delhi: The Bharat Biotech on Saturday (July 3, 2021) released the results from the Phase…

India inoculating population size of Norway everyday; drive a marathon, not 100-metre sprint: Govt

India is vaccinating on an average 50 lakh individuals daily since June 21, equivalent to inoculating…

‘Covaxin pricing clearly established’: Bharat Biotech clarifies on Brazil deal row

Image Source : PTI Bharat Biotech issues clarification on Brazil deal row Bharat Biotech on Wednesday issued…